| PERIOD ENDING | 4-Jul-09 | 4-Apr-09 | 31-Dec-08 | 27-Sep-08 | | Total Revenue | 408,591 | 407,940 | 396,753 | 395,005 | | Cost of Revenue | 179,693 | 184,621 | 191,392 | 185,835 | | | Gross Profit | 228,898 | 223,319 | 205,361 | 209,170 | | | Operating Expenses | | Research Development | 29,123 | 25,203 | 26,003 | 25,421 | | Selling General and Administrative | 130,749 | 126,788 | 132,769 | 123,974 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 69,026 | 71,328 | 46,589 | 59,775 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 176 | 8,784 | 354 | 213 | | Earnings Before Interest And Taxes | 69,202 | 80,112 | 46,943 | 59,988 | | Interest Expense | 14,477 | 14,609 | 12,783 | 13,899 | | Income Before Tax | 54,725 | 65,503 | 34,160 | 46,089 | | Income Tax Expense | 13,119 | 11,949 | 163 | 5,710 | | Minority Interest |
-
|
-
| (726) | (706) | | | | Net Income From Continuing Ops | 41,606 | 53,554 | 33,271 | 39,673 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 41,606 | 53,554 | 33,271 | 39,673 | | Preferred Stock And Other Adjustments | (1,212) | (529) |
-
|
-
| | | Net Income Applicable To Common Shares | $40,394 | $53,025 | $33,271 | $39,673 |
|
0.17% Nasdaq 
1.09 (1.59%) 
Income Statement
